« Back

New Chairman for surgical robotics innovator Prosurgics

28 Dec 2009

Prosurgics, the company championing affordable robotics for surgery announces the appointment of Mark Kirby as non-executive Chairman.  Mark (53), has over 25 years experience in emerging healthcare companies through the development cycle from small enterprises, through to public flotation and beyond.  Growing Medic-Aid Ltd and leading its MBO from the original owners, he subsequently floated the company in 2000 on the main London Stock Exchange as Profile Therapeutics plc.  It was subsequently purchased by Respironics Inc. in July 2004.  Since that time Mark has worked with a variety of high growth medical and pharma’ companies.  He is presently Chairman of Glide Pharma, a specialty pharmaceuticals company; and of Eykona technologies, which develops 3D imaging products for healthcare applications.  He is also non-executive director of Nigaard A/S, a Norwegian specialty pharma’ company.  Commenting on the prospects for Prosurgics’ business, Mark said “The Company’s real strength is in the relevance of the FreeHand product to the challenges surgeons are facing today – it responds to real needs of surgeons and hospitals to work smarter and more efficiently.  2009 has seen the business establish a very promising foothold in its launch markets, the opportunity is there in 2010 to build real growth”.


For further information please contact:

Colin Robertson, Global Marketing Director +44 (0)1344 742895 crobertson@prosurgics.com

About Prosurgics — Prosurgics is dedicated to pioneering a new generation of innovative but affordable surgical robots. Its range of robotic solutions helps improve patient outcomes and healthcare economics in hospitals around the world. The company's technology portfolio encompasses image guided and tele-manipulator systems, surgical planning and intra-operative navigation.

 

With offices in the UK (Bracknell), USA (Cupertino, CA) and Germany and a global network of expert distributors, Prosurgics delivers innovative and effective solutions for today's surgeons and hospitals around the world.

« Back